Francesca Biondo is currently the Medicine Team Lead for Hemophilia at Pfizer, where they lead the late-stage development of hemophilia therapies. With over 13 years of experience at Pfizer, Francesca has held various roles, including Global Clinical Lead and Medical Advisor for Rare Diseases. Francesca earned their Doctor of Medicine (M.D.) from Università degli Studi di Roma 'La Sapienza' and completed a Master's degree in Pre-clinical and Clinical Drug Development at Università Cattolica del Sacro Cuore. Prior to joining Pfizer, Francesca studied Haematology at the University of Rome from 2003 to 2012.
This person is not in any teams
This person is not in any offices